GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (AQSE:OPTI.GB) » Definitions » EV-to-Revenue

OptiBiotix Health (AQSE:OPTI.GB) EV-to-Revenue : 22.39 (As of Jun. 04, 2025)


View and export this data going back to 2015. Start your Free Trial

What is OptiBiotix Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, OptiBiotix Health's enterprise value is £12.74 Mil. OptiBiotix Health's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was £0.57 Mil. Therefore, OptiBiotix Health's EV-to-Revenue for today is 22.39.

The historical rank and industry rank for OptiBiotix Health's EV-to-Revenue or its related term are showing as below:

AQSE:OPTI.GB' s EV-to-Revenue Range Over the Past 10 Years
Min: 5.09   Med: 52.26   Max: 545.35
Current: 22.39

During the past 13 years, the highest EV-to-Revenue of OptiBiotix Health was 545.35. The lowest was 5.09. And the median was 52.26.

AQSE:OPTI.GB's EV-to-Revenue is ranked worse than
70.68% of 996 companies
in the Biotechnology industry
Industry Median: 7.385 vs AQSE:OPTI.GB: 22.39

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-04), OptiBiotix Health's stock price is £0.13. OptiBiotix Health's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was £0.01. Therefore, OptiBiotix Health's PS Ratio for today is 21.67.


OptiBiotix Health EV-to-Revenue Historical Data

The historical data trend for OptiBiotix Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health EV-to-Revenue Chart

OptiBiotix Health Annual Data
Trend Jul12 Nov14 Nov15 Nov16 Nov17 Nov18 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 151.61 33.45 17.76 24.14 36.89

OptiBiotix Health Semi-Annual Data
May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 24.14 - 36.89 -

Competitive Comparison of OptiBiotix Health's EV-to-Revenue

For the Biotechnology subindustry, OptiBiotix Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptiBiotix Health's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OptiBiotix Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where OptiBiotix Health's EV-to-Revenue falls into.


;
;

OptiBiotix Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

OptiBiotix Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=12.739/0.569
=22.39

OptiBiotix Health's current Enterprise Value is £12.74 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OptiBiotix Health's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was £0.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OptiBiotix Health  (AQSE:OPTI.GB) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

OptiBiotix Health's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.13/0.006
=21.67

OptiBiotix Health's share price for today is £0.13.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was £0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OptiBiotix Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of OptiBiotix Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


OptiBiotix Health Business Description

Traded in Other Exchanges
Address
Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.

OptiBiotix Health Headlines

No Headlines